INS and type 1 diabetes mellitus: Strikingly, pediatric patients developing type 1 diabetes, despite carrying this protective INS variant and receiving the current standard of clinical care, showed reduced insulin autoimmunity, preserved beta cell function, higher C-peptide levels, and improved glycemic control [9].